Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
During the Trading Day
| 4.60 |  +0.22 / +5.02% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 4.66 | +0.06 / +1.30% |
Volume: 33.4K |
Latest MACK News | Press Releases
| 5 Stocks Insiders Love Right Now 3:56pm / TheStreet.com | Biotech Week in Review Dec 02 / MotleyFool.com |
| Top Insider Trades: WHLR MACK MATR HNR Dec 03 / TheStreet.com | Benzinga's Top #PreMarket Gainers Dec 02 / Benzinga |
| Merrimack Pharmaceuticals (MACK) Jumps: Stock Rises 6.6% - Tale of the Tape Dec 03 / Zacks.com | Update on Merrimack's MM-121 - Analyst Blog Nov 29 / Zacks.com |
| MACK: Insiders Vs. Shorts Dec 02 / TheStreet.com | Biotech Stocks With Promise Nov 29 / TheStreet.com |
| The Big Pharma Stock Making Gains (and The One Suffering Big Losses) Dec 02 / TheStreet.com | Why Merrimack Pharmaceuticals Inc. Shares Soared Nov 26 / MotleyFool.com |
Today’s Trading
| Previous close | 4.38 |
| Today’s open | 4.40 |
| Day’s range | 4.40 - 4.72 |
| Volume | 5,657,059 |
| Average volume (3 months) | 1,869,722 |
| Market cap | $448.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 12/04/2013
Growth & Valuation
| Earnings growth (last year) | +82.04% |
| Earnings growth (this year) | +3.13% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +42.98% |
| P/E ratio | NM |
| Price/Sales | 9.07 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ECYTEndocyte Inc | -0.08 | -0.71% |
| RGENRepligen Corp | -0.07 | -0.53% |
| ACRXAcelRx Pharmaceutica... | -0.14 | -1.52% |
| RCPTReceptos Inc | -0.20 | -0.87% |
Data as of 4:00pm ET, 12/04/2013
Financials
| Next reporting date | March 13, 2014 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $48.9M |
| Annual profit (last year) | -$91.3M |
| Net profit margin | -186.58% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Robert J. Mulroy |
Senior Vice President- Operations William M. McClements |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
